Hydrogen bonding in crystal forms of primary amide functionalized glucose and cellobiose by Moynihan, Humphrey A. et al.
Title Hydrogen bonding in crystal forms of primary amide functionalized
glucose and cellobiose
Author(s) Moynihan, Humphrey A.; Hayes, John A.; Eccles, Kevin S.; Coles,
Simon J.; Lawrence, Simon E.
Publication date 2013-06
Original citation MOYNIHAN, H. A., HAYES, J. A., ECCLES, K. S., COLES, S. J. &
LAWRENCE, S. E. 2013. Hydrogen bonding in crystal forms of primary
amide functionalised glucose and cellobiose. Carbohydrate Research,
374, 29-39. http://dx.doi.org/10.1016/j.carres.2013.03.024
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://www.sciencedirect.com/science/article/pii/S0008621513001122
http://dx.doi.org/10.1016/j.carres.2013.03.024
Access to the full text of the published version may require a
subscription.
Rights Copyright © 2013 Elsevier Ltd. All rights reserved. NOTICE: this is
the author’s version of a work that was accepted for publication in
Carbohydrate Research. Changes resulting from the publishing
process, such as peer review, editing, corrections, structural
formatting, and other quality control mechanisms may not be
reflected in this document. Changes may have been made to this
work since it was submitted for publication. A definitive version was
subsequently published in Carbohydrate Research, [Volume 374, 7
June 2013, Pages 29–39] DOI
http://dx.doi.org/10.1016/j.carres.2013.03.024
Item downloaded
from
http://hdl.handle.net/10468/1588
Downloaded on 2017-02-12T09:37:57Z
1 
 
Hydrogen bonding in crystal forms of primary amide 
functionalized glucose and cellobiose 
 
Humphrey A. Moynihana*, John A. Hayesa, Kevin S. Ecclesa, Simon J. Colesb, 
Simon E. Lawrencea  
 
aDepartment of Chemistry / Analytical and Biological Chemistry Research Facility, 
University College Cork, College Road, Cork, Ireland 
bUK National Crystallographic Service, School of Chemistry, University of Southampton, 
Highfield, Southampton, SO17 1BJ, UK 
 
ABSTRACT 
A glucoside and cellobioside of glycolamide were synthesised and the crystal chemistry of 
these compounds investigated.  The amidoglucoside crystallised in the P21 space group.  The 
primary amide group participates in C(7) and C(17) chains also involving the pyranose 
oxygen and hydroxyl groups.  The amidocellobioside crystallised as a methanol solvate in the 
P21 space group.  The amide N-H groups donate hydrogen bonds to oxygen atoms on the 
cellobiose units, while intramolecular hydrogen bonds give rise to S(7) and S(9) motifs in 
addition to a R 3 3  (9) motif.  A tetra-O-acetylglucoside derivative of thioglycolamide and its 
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sulfoxide derivative were synthesied to examine the effect of protecting the glucopyanose 
hydroxyl groups.  The thioglycolamido derivative, which crystallised in the P212121 space 
group, featured amide N-H groups donating to the glucopyranose oxygen and an acetyloxy 
group.  The sulfoxy derivative crystallised in the P21 space group and featured the primary 
amide groups forming R 2 3 (8) motifs generating a P21 ladder. 
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1. Introduction 
Crystal engineering is the control of molecular assembly in crystals with the ultimate aim of 
controlling properties which arise from the collective participation of molecules in the 
crystalline array such as density, melting point, solubility, mechanical and thermal 
characteristics.1  For sugars and carbohydrates, these crystal state properties affect activities 
such as hygroscopicity, flow, blending, compression into tablets and other operations of 
commercial importance.2  An ability to control the molecular assembly of sugar molecules in 
crystalline solids in a rational manner would have applications in areas such as 
pharmaceutical formulation using sugar-derived excipients.  Crystal engineering exploits 
'supramolecular synthons', these being structural units within crystals which assemble by 
known intermolecular interactions.3  Amides, which form well known hydrogen bonded 
3 
 
motifs in the solid state, are good examples of such synthons.4  In particular, primary amide 
groups are associated with important supramolecular motifs often occurring in crystal 
structures, such as dimers and 'amide ladders'.5  These motifs are conveniently described 
using the notation devised by Etter, for example the common amide dimer motif can be 
described as an R 2 2 (8) dimer.6   The functional groups generally present in sugars: alcohols, 
acetals and ketals, have not been widely exploited in crystal engineering.  The crystal 
chemistry of sugars generally focuses on features such as pyranose ring puckering 
characterised by Cremer-Pople parameters,7 torsional angles for primary hydroxyls and acetal 
linkages8 and conformational or supramolecular features specific to classes of 
monosaccharide or polysaccharide.9   
Carefully designed structural modifications can be used to provide insights into physical or 
crystallographic aspects of sugars. For example, modified sugars can provide information of 
the details of enzyme-sugar binding,10 can act as models for complex biomolecules11 or can 
provide information on interactions between sugar-based groups.12  The work described 
herein aims to investigate whether incorporation of conventional supramolecular synthons, in 
particular primary amides, into sugars gives rise to motifs such as R 2 2 (8) dimers, which 
could be used as a basis for crystal engineering; or whether alternatively, the hydrogen 
bonding capabilities of the sugar and amide group form new exploitable motifs.  To achieve 
this aim, a short series of primary amido-functionalised glucose and cellobiose derivatives 
have been prepared and the crystal chemistry of these determined.  These molecules are 
designed to have distinct sugar and amide domains in contrast to, for example, N-
acetylglucosamine, in which the amide group is directly substituted on the glucopyranose 
ring.  Crystallisation and crystal structure determination of the resulting primary amide 
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functionalised glucose and cellobiose compounds were then carried out to probe the hydrogen 
bonding networks thus formed. 
 
2. Results and discussion 
2.1. Preparation of primary amide functionalised glucose and cellobiose derivatives 
Primary amide functionalized derivatives of glucose and cellobiose were synthesized from 
the corresponding trichloroacetimidates as outline in Scheme 1, i.e by conversion of the 
trichloroacetimdates 1 and 5 to the corresponding methyl glycolate derivates 2 and 6, 
followed by treatement of these with ammonia in methanol to give the required primary 
amide functionalised glucose and cellobiose derivatives, 3 and 7 respectively. 
 
<Scheme 1 about here> 
 
 
2.2. Crystal structures of primary amide functionalised glucose 3 and cellobiose 7 
Crystals of compounds 3 and 7 suitable for analysis by single-crystal X-ray diffraction were 
grown by slow evaporation of solutions in ethanol and methanol respectively.  Both 
compounds crystallized in the monoclinic P21 space group.  Crystallographic data are given 
in Table 1.  Table 2 gives the hydrogen bond data obtained from PLATON.13 
 
<Table 1 about here> 
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<Table 2 about here> 
 
The glucopyranose ring of compound 3 adopts a 4C1 conformation with the corresponding 
Cremer-Pople parameters given in Table 3.  These values are close to the corresponding 
values for an ideal cyclohexane chair (Q = 0.63 Å, θ = 5.0 °).7  The dihedral angle around the 
primary hydroxyl group on C-6 is 75.54 o indicating a gauche-trans conformation.  The 
primary amide forms a discrete hydrogen bond between one of the amide N-H and the 
heterocyclic oxygen of an adjacent glucopyranose ring, forming C(7) chains along the b axis 
(Figure 1 and 2), i.e. hydrogen bonded chains consisting of a repeat unit containing 7 atoms.  
The amide oxygen also accepts a hydrogen bond from the primary hydroxyl, forming a C(17) 
chain with two molecules in the repeat unit (Figures 3 and 4).  It should be noted that while 
crystallisation from ethanol gave crystals (m.p. 155.0 °C by DSC) of compound 3 suitable for 
single-crystal XRD, crystallisation from methanol gave crystals of melting point 165.5 °C 
(DSC), possibly another crystal form such as a polymorph or solvate.  However these latter 
crystals were highly agglomerated and were not suitable for single-crystal analysis. 
 
<Table 3 about here> 
 
 
<Figure 1 about here> 
 
<Figure 2 about here> 
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<Figure 3 about here> 
 
<Figure 4 about here> 
 
Single-crystal XRD analysis of crystals of compound 7 shows that the form obtained was a 
methanol solvate. Cremer-Pople parameters (Table 3) for the glucopyranose rings of both the 
reducing end and the non-reducing end were consistent with 4C1 conformations.  The 
dihedral angle about the primary hydroxy group in the non-reducing pyranose is −60.75 ° 
while that for the reducing pyranose is −75.06 °, equivalent to gauche-gauche conformations 
in both cases.  The angle at the oxygen joining the pyranose rings is 115.3 °.  The amide N-H 
groups are donating hydrogen bonds to the 3-OH of one molecule and the 6'-OH of another, 
while the amide carbonyl accepts a hydrogen bond from the methanol molecule (Figure 5 and 
6).  Intramolecular hydrogen bonds are observed between O3-H and the oxygen of the non-
reducing pyranose, and O2'-H and O6, giving rise to 7-membered and 9-membered 
intramolecular hydrogen bonded motifs, designated as S(7) and S(9) motifs respectively 
using Etter's notation (Figures 7 and 8).6  A similar S(9) motif involving an O6-H...O2' bond 
was observed in the structure of cyclohexyl 4'-O-cyclohexyl β-D-cellobioside cyclohexane 
solvate.14  The O2-H of a separate molecule accepts a hydrogen bond from the O6'-H and 
donates a hydrogen bond to the O3 forming a hydrogen bonded ring, designated as a R 3 3  (9) 
motif using Etter's notation,6 which also involves the O3-H...O intramolecular hydrogen bond 
(Figure 7 and 8).  In the structure, the molecules form layers that cross each other as shown in 
Figure 9, rather than a herringbone pattern.  A comparable crystal structure for compound 7 is 
that of methyl β-cellobioside methanol solvate which also crystallised in the P21.15  
However, significant differences were observed in the interaction of the methanol molecule 
and in intramolecular hydrogen bonding. Whereas in compound 7, the solvated methanol is 
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seen to hydrogen bond to the amide carbonyl, in the structure of methyl β-cellobioside 
methanol solvate the methanol molecule is hydrogen bonded to the primary hydroxyl of the 
reducing glucopyranose.  Also in the structure of methyl β-cellobioside methanol solvate, the 
3-position hydroxyl of the reducing glucopyranose is participating in a hydrogen bonded ring 
involving the non-reducing pyranose oxygen and primary hydroxyls, unlike the hydrogen 
bonding motifs illustrated in Figure 8. 
Also in the structure of 7.MeOH, there is a short contact of 2.1 Å between H1' and H4.  Both 
C-H bonds are axial and approximately parallel.  Compound 7 is a good subject for prediction 
of properties of a helix consisting of repetition of either of the glucopyranose rings.  The 
parallel C1'-H and C4-H bonds would correspond to a twofold screw axis if present in an 
extended cellulose-like polymer.16  Extrapolation of helix properties from crystal structure 
data of small molecule glucopyranose derivatives has been developed by French and Johnson 
as a technique for obtaining data on model cellulose chains.17  The necessary input for the 
extrapolation are the virtual bond length of the glucopyranose residue, i.e. the O1-O4 
distance, the virtual angle formed by two such rings and the virtual torsion angle formed by 
three such rings. Using the non-reducing glucopyranose of compound 7 as such a model and 
the formulae given by French and Johnson gives the predicted number of glucopyranose 
residues per turn of the model helix as −2.19, indicating a left-handed helix which advances 
5.19 Å per glucopyranose residue.  These values are within the ranges given by French and 
Johnson based on calculations using data from twenty-three small molecules.17 
 
<Figure 5 about here> 
 
<Figure 6 about here> 
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<Figure 7 about here> 
 
<Figure 8 about here> 
 
<Figure 9 about here> 
 
2.3. Preparation of acetylated sulfide-amido, sulfoxide-amido and sulfonyl-amido 
glucose derivates 
In the crystal structures for compounds 3 and 7 discussed above, the primary amide groups 
are involved in hydrogen bonding with pyranose hydroxyls or oxygens rather than generating 
familiar primary amide motifs such as 'amide ladders'.  This is not very surprising as the 
glucopyranose groups offer extensive hydrogen bond donating and accepting capacity, 
although it might have been hoped that a degree of molecular recognition may have existed 
between the amide groups.  This could be moderated by blocking the hydroxyls so as to 
reduce the hydrogen bond donating capacity of the glucopyranoses.  Such derivatives would 
be protected glucosides and therefore would not display the full supramolecular 
characteristics of sugars in the crystalline solid state.  However, informative supramolecular 
solid state chemistry would still be obtained and it would be possible to evaluate whether 
typical amide supramolecular motifs were possible with such systems under any 
circumstances.  The sulfide and sulfoxide linked peracetylated glucosyl primary amides 9 and 
10 were synthesized for this purpose.  While the sulfide linkage in compound 9 was formed 
primarily to bind the amide and peracetyl glucose regions, the option of further oxidising 
these to the sulfoxide 10 and sulfone 11 was an obvious extension of the system (Scheme 2). 
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Amidosulfide 9 was obtained by reaction of glucose pentaacetate 8 with thiourea in the 
presence of BF3.Et2O, generating a thiouronoium intermediate in situ which was 
subsequently hydrolysed and the resulting thiolate reacted with chloroacetamide.  Careful 
oxidation with Oxone® gave the sulfoxide 10, while oxidation of 9 with mCPBA gave the 
sulfone 11.  Sulfoxide 10 appeared to be a single diastereoisomer by NMR although the yield 
of isolated product was very modest (33%) so that formation of some quantity of the epimeric 
sulfoxide which would have been removed during purification cannot be ruled out. 
 
 
2.4. Crystal structures of acetylated sulfide-amido glucose derivative 9 and sulfoxide-
amido glucose derivate 10 
Crystals of compounds 9 and 10 suitable for single-crystal X-ray analysis were obtained by 
allowing undersaturated solutions of 9 and 10 in methanol to slowly evaporate at ambient 
temperature, however suitable crystals of sulfone 11 were not obtained.  Crystallographic 
data for compounds 9 and 10 are given in Table 1. 
 
<Scheme 2 about here> 
 
 
Compound 9 crystallised in orthorhombic P212121 space group.  Cremer-Pople parameters 
(Table 3) are consistent with a 4C1 conformation.  The amide N-H groups donate hydrogen 
bonds to the pyranose oxygen and the carbonyl group of the 2-acetoxy group of adjacent 
molecules (Figures 10 and 11). 
 
<Figure 10 about here> 
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<Figure 11 about here> 
 
Compound 10 crystallised as monoclinic P21.  Compound 10 has Cremer-Pople parameters 
(Table 3) relating to typical 4C1 values.  The primary amide groups form C(4) hydrogen 
bonded chains.  In each amide group, the N-H not involved in the C(4) motif is donating a 
hydrogen bond to an amide carbonyl in a parallel chain forming a series of R 2 3 (8) rings, 
giving rise to a ladder-like motif referred to as a 21 axis18 (Figures 12 and 13), although not 
the more common 'amide ladder' composed of R 2 2 (8) rings.  The sulfur atom of the sulfoxide 
group is a stereogenic centre having S configuration. The packing observed in the structure of 
compound 10 would appear to maximize density as illustrated by Figure 14. 
 
<Figure 12 about here> 
 
<Figure 13 about here> 
 
<Figure 14 about here> 
 
2.5. Conclusion 
Primary amide derivatives of glucose and cellobiose, compounds 3 and 7, have been prepared 
and their crystal structures determined.  These structures did not display common amide type 
motifs such as C(4) chains and R 2 2 (8) dimers, but rather motifs involving both sugar and 
amide groups.  For compound 3, a C(17) chain with two molecules in the repeat unit was 
observed.  For compound 7, the amide N-H groups donated hydrogen bonds to oxygen atoms 
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on the cellobiose units, while intramolecular hydrogen bonds giving rise to S(7) and S(9) 
motifs were observed in addition to a R 3 3 (9) motif.  Sulfide 9, in which the glucopyranose 
hydroxyls were acetylated, displayed amide N-H groups donating to glucopyranose oxygen 
and an acetyloxy group.  However, sulfoxide 10 displays an interesting ladder-like motif 
composed from R 2 3 (8) rings.  This motif, also known as a primary amide 21 axis motif, is not 
as common as the amide ladder but has been observed in crystal structure of some primary 
amides, for example adipamide and 2-chlorobenzamide.18 
The structures studied generally display individual hydrogen bonding patterns featuring 
motifs involving both primary amide and sugar groups rather than distinct amide-based and 
sugar-based motifs.  In the case of the acetylated amidoglucosyl sulfoxide 10, a characteristic 
primary amide motif was observed.  Hence for three of the compounds studied, the degree of 
molecular recognition between the primary amide groups was not strong enough to drive 
formation of crystal structures based on distinct amide and sugar motifs, at least in the crystal 
forms obtained, while specific supramolecular interactions between the primary amide groups 
were observed in the acetylated sulfoxide 10.  This suggests that crystal engineering of sugars 
through exploitation of primary amide motifs may be possible.  However, modification of the 
hydroxy groups and/or inclusion of further functionality may be necessary which would limit 
applications.  Another possibility is that further research on the nucleation and growth of 
compounds such as 3 and 7 may generate new crystal forms with distinct amide and sugar 
motifs.  Alternatively, modification of the amide functionality, e.g. addition or removal of 
methylene groups, may produce compounds with such crystal structures. 
 
 
3. Experimental 
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3.1. General methods 
All commercial reagents were purchased from Sigma-Aldrich and were used without further 
purification.  All solvents were either of a HPLC grade or distilled prior to use.  Column 
chromatography was conducted using Merck silica gel 60, typically with a 30:1 ratio of silica 
to sample.  Infrared spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR 
spectrometer.  The 1H NMR spectra were recorded on a Bruker AVANCE 300 MHz 
spectrometer.  Chemical shift values (δH and δC) are expressed as parts per million (ppm).  
Elemental analyses were performed by the Microanalysis Laboratory, University College 
Cork, using an Exeter Analytical CE440 elemental analyzer.  High resolution mass spectra 
(HRMS) were recorded on a Waters LCT Premier LC-MS instrument in electrospray 
ionisation (ESI) positive mode using 50 % MeCN-H2O containing 0.1 % HCO2H as eluant; 
samples were made up in MeCN. 
 
3.2. Synthesis 
3.2.1. Methyl 1-O-(-2-Carboxy)methyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose (2) 
2,3,4,6-Tetra-O-acetyl-1-O-trichloroacetimidoyl-α-D-glucopyranose19 1 (1.50 g, 3.05 mmol) 
was stirred in dry CH2Cl2 (30 mL) along with methyl glycolate (0.26 mL, 3.36 mmol) over 
4Å mol sieves at −25 oC. BF3.Et2O (0.41 mL, 3.36 mmol) was added and the solution was 
allowed to slowly warm to room temperature.  After 4 to 5 h, the solution was filtered and 
washed with sat. aq. NaHCO3 soln. (2 × 20 mL), H2O (2 × 20 mL) and brine (20 mL).  The 
solvent was removed in vacuo and the resulting residue was purified with column 
chromatography using EtOAc: hexane to yield a white solid (0.95 g, 74%).  IR (KBr); ν 2958 
(C-H), 1756 (C=O), 1371 (CH), 1235 (O-C=O) and 1045 cm-1 (O-C-O); 1H NMR  (CDCl3): 
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δ 1.95 (3H, s, OAc), 1.96 (3H, s, OAc), 2.02 (3H, s, OAc), 2.03 (3H, s, OAc), 3.63 (1H, ddd, 
3J = 9.0, 4.8, 2.4 Hz, H-5), 3.69 (3H, s, OCH3), 4.07 (1H, dd, 2J = 12.0, 3J = 2.4 Hz, H-6), 
4.19 (1H, dd, 2J = 12.0, 3J = 4.8 Hz, H-6’), 4.23 (2H, s, OCH2CO2Me), 4.60 (1H, d, 3J = 7.8 
Hz, H-1), 4.98 (1H, dd, 3J = 9.0, 7.8 Hz, H-2), 5.02 (1H, t, 3J = 9.0 Hz, H-4), 5.18 (1H, t, 3J = 
9.0 Hz, H-3); 13C NMR (CDCl3): δ 19.59 (CH3), 19.60 (CH3), 19.71 (CH3), 19.72 (CH3), 
50.98 (OCH3), 60.77 (C-6), 63.94 (CH2), 67.29 (C-4), 69.92 (C-2), 70.93 (C-5), 71.50 (C-3), 
99.11 (C-1), 168.42, 168.60, 168.66, 169.18, 169.65 (4 × OAc, 1 × CO2Me). 
 
 
3.2.2. 1-O-(2-Carboxamido)methyl-β-D-glucopyranose (3) 
 Methyl 1-O-(-2-carboxy)methyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose 2 (1.00 g, 2.39 
mmol) was stirred in 2M NH3 in MeOH soln. (20 mL, 40 mmol) for 1 h.  The methanolic 
ammonia was removed under reduced pressure and the crude residue was recrystallised from 
a minimum of hot MeOH to yield a white solid (0.55 g, 99 %).  Mp 165.49 oC; IR (KBr); ν 
3422 (OH, NH), 2923 (CH), 1672 (NHC=O), 1379 (CH), 1325 (CH), 1222 (O-C=O) and 
1132 cm-1 (C-O-C); 1H NMR  (d6-DMSO): δ 3.41-3.48 (1H, m), 3.67 (1H, ddd, 3J = 9.9, 6.3, 
1.8 Hz), 3.89 (1H, d, 2J = 15.0 Hz, OCH2CO2Me), 4.09 (1H, d, 2J = 15.0 Hz, OCH2CO2Me), 
4.16 (1H, d, 3J = 9.0 Hz, H-1), 4.55 (1H, t, 3J = 6.0 Hz), 4.95 (1H, d, 3J = 6.0 Hz), 5.02 (1H, 
d, 3J = 3.0 Hz), 5.51 (1H, d, 3J = 3.0 Hz), 7.42 (2H, br s, NH2); 13C NMR (d6-DMSO): δ 
60.90 (CH2), 47.81 (CH2), 69.88 (CH), 73.35 (CH), 76.16 (CH), 76.98 (CH), 103.02 (C-1), 
171.57 (CONH2). 
 
3.2.3. Preparation of α-D-Glucopyranose-4-O-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)-2,3,6-triacetyl-1-O-trichloroacetimidate (5) 
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To a solution of β-D-glucopyranose-4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-, 
1,2,3,6-tetraacetate (4) (2.0 g, 2.94 mmol) in THF was added benzylamine20 (0.35 mL, 3.24 
mmol) and the solution was stirred at ambient temperature for 12 h.  The solvent was 
removed in vacuo and the resulting syrup was dissolved in CHCl3 (150 mL). The organic 
phase was washed with 1M HCl (2 × 30 mL), water (2 × 30 mL) and brine (30 mL), dried 
over MgSO4 and the solvent removed under reduced pressure.  The crude solid was subjected 
to column chromatography with ethyl acetate: hexane (1:1) as eluant, to yield α/β-D-
glucopyranose-4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-2,3,6-triacetate as a white 
solid (1.21 g, 64% yield) as a 3.2:1 mix of anomers (α:β) (by NMR integration) 1H NMR 
(CDCl3, α anomer) δ: 1.93 (3H, s), 1.96 (3H, s), 1.98 (3H, s), 2.02 (3H, s), 2.04 (3H, s), 2.08 
(3H, s), 2.09 (3H, s), 3.64-3.61 (1H, m), 3.71 (1H, t, 3J = 9.2 Hz), 3.82-3.96 (2H, m), 4.14 - 
3.98 (1H, m), 4.30 (1H, dt, 3J = 6.7, 3.9 Hz), 4.51 - 4.45 (2H, m), 4.79 - 4.69 (1H, m), 4.88 
(1H, ddd, 3J = 9.0, 6.0, 3.0 Hz), 5.16 - 4.99 (2H, m), 5.31 (1H, t, 3J = 4.3 Hz), 5.45 (1H, t, 3J 
= 9.0 Hz). 13C NMR δC (CDCl3): 20.64 (2xCH3), 20.74 (2xCH3), 20.85 (CH3), 20.94 
(2xCH3), 61.77 (CH2), 62.00 (CH2), 68.00 (CH), 68.29 (CH), 69.55 (CH), 71.52 (CH), 71.83 
(CH), 72.06 (CH), 72.22 (CH), 73.11 (CH), 73.19 (CH), 73.42 (CH), 90.15 (CH), 95.35 (C-1, 
unknown anomer), 100.96 (C-1, unknown anomer), 100.97 (CH), 169.30 (OAc), 169.56 
(OAc), 169.96 (OAc), 170.53 (OAc), 170.64 (OAc), 170.84 (OAc), 170.92 (OAc).  The α/β-
D-glucopyranose-4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-2,3,6-triacetate obtained 
(5.0 g, 7.86 mmol) and Cl3CCN (1.57 mL, 15.72 mmol) were stirred in dry CH2Cl2 (80 mL) 
at 0 oC for 30 min.  DBU (0.12 mL, 0.78 mmol) was added dropwise and the solution was 
allowed warm to room temperature and stirred for 12 h.  The solvent was removed in vacuo 
and the residue was subjected to silica gel chromatography (40:60 EtOAc:hexane) to yield a 
foam (3.18 g, 52%); 1H NMR  (CDCl3): δ 1.99 (3H, s, OAc), 2.01 (3H, s, OAc), 2.02 (3H, 
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OAc), 2.03 (3H, s, OAc), 2.04 (3H, s, OAc), 2.09 (3H, s, OAc), 2.10 (3H, s, OAc),  3.66 (1H, 
ddd, 3J = 9.0, 6.0, 3.0 Hz, H-5’), 3.84 (1H, t, 3J = 9.0 Hz, H-4),  4.02-4.15 (3H, m, H-5, H-6), 
4.39 (1H, dd, 3J = 12.0, 3.0 Hz, H-6’), 4.49-4.56 (2H, m), 4.94 (1H, t, 3J = 9.0 Hz), 5.04-5.15 
(3H, m, H-2), 5.53 (1H, t, 3J = 9.0 Hz, H-3), 6.48 (1H, d, 3J = 3.9 Hz, H-1), 8.66 (1H, s, NH); 
13C NMR (CDCl3): δ 20.49 (CH3), 20.57 (CH3), 20.63 (2 × CH3), 20.70 (2 × CH3), 20.84 
(CH3), 61.38 (C-6), 61.55 (C-6’), 67.70 (CH), 69.29 (CH), 69.86 (CH), 70.96 (CH), 71.67 
(CH), 72.02 (CH), 73.06 (CH), 76.12 (CH),  92.86 (C-1), 100.98 (C-1), 160.98 (Cq), 169.09 
(OAc), 169.29 (OAc), 169.46 (OAc), 170.06 (OAc), 170.17 (OAc), 170.28 (OAc), 170.50 
(OAc). 
 
3.2.4. Methyl 1-O-(2-Carboxymethyl)-2,2',3,3',4',6,6'-hepta-O-acetyl-β-D-cellobiose (6) 
α-D-Glucopyranose-4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-2,3,6-triacetyl-1-O- 
trichloroacetimidate 5 (2.0 g, 2.56 mmol) and methyl glycolate (0.22 mL, 2.82 mmol) was 
stirred in dry CH2Cl2 (60 mL) over 4Å mol sieves at −25 oC. BF3.Et2O (0.35 mL, 2.82 
mmol) was added and the solution was allowed to warm slowly to room temperature.  After 
4-5 h, the solution was filtered and washed with sat. aq. NaHCO3 soln. (2 × 20 mL), H2O (2 
× 20 mL) and brine (20 mL).  The solvent was removed in vacuo the resulting residue was 
purified with column chromatography using EtOAc: hexane to yield a white solid (1.21 g, 67 
%).  IR (KBr); ν 2958 (C-H), 1756 (C=O), 1371 (CH), 1235 (O-C=O) and 1045 cm-1 (O-C-
O); 1H NMR  (CDCl3): δ 1.98 (3H, s, OAc), 2.01 (3H, s, OAc), 2.03 (6H, s, 2 × OAc), 2.08 
(3H, s, OAc), 2.09 (3H, s, OAc), 2.12 (3H, s, OAc), 3.59 (1H, ddd,  3J = 6.0, 3.0, 1.5 Hz, H-
5’), 3.65 (1H, ddd, 3J = 6.0, 3.0, 1.5 Hz, H-5),  3.74 (3H, s, OCH3), 3.80 (1H, t, 3J = 9.0 Hz), 
4.00-4.10 (2H, m), 4.25 (2H, s, OCH2CO2Me), 4.36 (1H, dd, 3J = 9.0, 3.0 Hz), 4.50-4.54 
(2H, m), 4.69 (1H, d, 3J = 7.8 Hz, H-1), 4.93-4.89 (2H, m), 5.06 (1H, t, 3J = 9.1 Hz), 5.14 
16 
 
(1H, t, 3J = 9.0 Hz), 5.21 (1H, t, 3J = 9.0 Hz); 13C NMR (CDCl3): δ 20.55 (4 × CH3), 20.67 
(CH3), 20.73 (CH3), 20.85 (CH3), 51.98 (OCH3), 61.54 (C-6), 61.64 (C-6'), 65.10 
(CH2CO2Me), 67.77 (CH), 71.19 (CH), 71.60 (CH), 71.93 (CH), 72.12 (CH), 72.83 (CH), 
72.92 (CH), 76.29 (CH), 100.00 (C-1), 100.74 (C-1'), 169.01, 169.30, 169.51, 169.71, 169.86 
, 170.23, 170.28, 170.50 (7 × OAc, 1 × CO2Me). 
 
3.2.5. 1-O-(2-Carboxamido)methyl-4-O-(β-D-glucopyranosyl)-β-D-glucopyranose (7)  
 Methyl 1-O-(2-carboxymethyl) 2,2',3,3',4,6,6’-hepta-O-acetyl-β-D-cellobiose 6 (1.5 g, 2.12 
mmol) was stirred in a 2M NH3 in MeOH soln. (30 mL, 60 mmol) for 1 h.  The methanolic 
ammonia was removed under reduced pressure and the crude residue was recrystallised from 
a minimum of hot MeOH to yield a white solid (0.81 g, 97%).  Mp 135.5 oC; IR (KBr): ν 
3414 (OH and NH2), 2917 (CH), 1675 (CO) and 1077 cm-1 (C-O-C); 1H NMR (D2O): δ 3.32 
(1H, t, J = 9.0 Hz), 3.38-3.54 (4H, m), 3.58-3.68 (3H, m), 3.74 (1H, dd, 3J = 12.3, 5.7 Hz), 
3.83 (1H, dd, 3J = 12.3, 4.8 Hz), 3.92 (1H, dd, 3J = 12.3, 1.8 Hz), 3.98 (1H, dd, 3J = 12.0, 1.8 
Hz), 4.27 (1H, d, 3J = 15.9 Hz, OCH2CO2Me), 4.39 (1H, d, 3J = 15.9 Hz, OCH2CO2Me), 
4.52 (1H, d, 3J = 7.8 Hz, H-1), 4.55 (1H, d, 3J = 7.8 Hz, H-1’); 13C NMR (D2O): δ 59.86 
(CH2), 60.58 (CH2), 67.77 (OCH2), 69.46 (CH), 72.73 (CH), 73.15 (CH), 74.11 (CH), 74.87 
(CH), 75.50 (CH), 75.99 (CH), 78.43 (CH), 102.24 (C-1), 102.57 (C-1), 175.04 (CONH2); 
calcd. C14H25NO12Na, 422.1275; found 422.1249 [M+Na+]. 
 
3.2.6. 1-S-(-2-Carboxamido)methyl-1-deoxy-1-thio-2,3,4,6-tetra-O-acetyl-β-D-
glucopyranose (9)  
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To a solution of β-D-glucose pentaacetate 8 (9.8 g, 25.12 mmol) in MeCN was added 
BF3.Et2O (3.08 mL, 37.5 mmol) followed by thiourea (1.91 g, 50.24 mmol). The solution 
was heated to reflux for 4 h. On cooling to room temperature, 2-chloroacetamide (2.34 g, 
27.5 mmol) was added followed by Et3N (10 mL). The solution was stirred for 1 h and the 
solvent removed in vacuo, the resulting syrup was dissolved in CHCl3 (150 mL) and washed 
with H2O (2 × 50 mL), brine (1 × 50 mL), dried (MgSO4) and the solvent removed under 
reduced pressure. The resulting foam was recrystallised from hot MeOH to yield a pale 
yellow solid (5.1 g, 48 %). Mp 160.47 oC; IR (KBr) ν 3387 (NH), 2943 (CH), 1734 (C=O), 
1644 (NHC=O), 1379 (CH), 1232 (O-C=O), 1031 (O-C-O) and 916 cm-1; 1H NMR (CDCl3) 
δ  1.95 (3H, s, OAc), 1.97 (3H, s, OAc), 2.00 (3H, s, OAc), 2.03 (3H, s, OAc), 3.16 (1H, d, 2J 
= 15.0 Hz, SCH2CONH2), 3.40 (1H, d, 2J = 15.0 Hz, SCH2CONH2), 3.69 (1H, dt, 3J = 9.3, 
3.9 Hz, H-5), 4.12 (2H, d, 3J = 3.9 Hz, H-6+6’), 4.53 (1H, d, 3J = 9.3 Hz, H-1), 4.98 (1H, t, 3J 
= 9.3 Hz, H-2), 5.01 (1H, t, 3J = 9.3 Hz,  H-4), 5.17 (1H, t, 3J = 9.3 Hz, H-3), 5.75 (1H, br s, 
NH), 6.60 (1H, br s, NH’); 13C NMR (CDCl3): δ 20.15 (CH3), 20.54 (CH3), 20.62 (CH3), 
20.70 (CH3), 33.78 (CH2), 61.66 (C-6), 68.07 (C-4), 69.60 (C-2), 73.48 (C-3), 76.21 (C-5), 
83.71 (C-1), 169.36 (CONH2), 169.41 (OAc), 170.04 (OAc), 170.60 (OAc), 171.26 (OAc); 
Anal Calcd for C16H21NO10S: C, 45.82; H, 5.05; N, 3.34. Found C, 45.45; H, 5.50, N, 3.21. 
 
3.2.7 1-S-(-2-Carboxamido)methyl-1-deoxy-1-sulfinyl-2,3,4,6-tetra-O-acetyl-β-D-
glucopyranose (10) 
Oxone® (1.46 g, 4.77 mmol) was added to a solution of 1-S-(-2-carboxamido)methyl-1-
deoxy-1-thio-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose 9 (2.0 g, 4.77 mmol) in a 1:1 mixture 
of MeCN:H2O (50 mL) and the mixture was stirred for 12 h.  The solution was filtered and 
the solvent removed in vacuo.  The syrup was dissolved in CHCl3 (100 mL) and the organic 
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phase was washed with H2O (2 × 20 mL), brine (20 mL), dried (MgSO4) and the solvent 
removed under reduced pressure.  The resulting foam was purified by column 
chromatography using EtOAc (100 %) as eluant to yield a white solid (0.15 g, 33 %) Mp 
194.2 oC; IR (KBr) ν  3387 (NH), 2943 (CH), 1735 (C=O), 1644 (NHC=O), 1379 (CH), 1232 
(O-C=O) and 1031 cm-1 (C-O-C); 1H NMR  (CDCl3) δ 2.00 (3H, s, OAc), 2.06 (6H, s, 2 × 
OAc), 2.08 (3H, s, OAc), 3.64 (1H, d, 2J = 15.0 Hz, S(O)CH2CONH2), 3.87 (1H, d, 2J = 15.0 
Hz, S(O)CH2CONH2), 4.11-4.26 (3H, m, H-6+6’, H-5), 5.04 (1H, d, 3J = 9.3 Hz, H-1), 5.05 
(1H, t, 3J = 9.3 Hz, H-4), 5.28 (1H, t, 3J = 9.3 Hz, H-2), 5.47 (1H, t, 3J = 9.3 Hz, H-3), 7.43 
(1H, br s, NH), 7.81 (1H, br s, NH’). 13C NMR δC: 20.28 (CH3), 20.34 (CH3), 20.49 (CH3), 
20.50 (CH3), 54.62 (SCH2CONH2), 61.71 (C-6), 67.20 (C-2), 67.36 (C-4), 72.98 (C-3), 
75.14 (C-5), 88.41 (C-1), 166.13 (CONH2), 168.79 (OAc), 169.2 (OAc), 169.63 (OAc), 
170.01 (OAc). C16H21NO11S calcd: C, 44.14; H, 4.86; N, 3.28; found C, 44.20; H, 4.83; N, 
2.70. MS-ESI: Found m/z, 460.0857; calcd for C16H23NO11SNa [M+Na+], 460.0890. 
 
3.2.8 1-S-(-2-Carboxamido)-1-deoxy-1-sulfonyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
(11)  
Methyl 1-S-(-2-carboxamido)-1-deoxy-1-thio-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose 9 
(2.0 g, 4.77 mmol) was dissolved in CHCl3 (60 mL) along with mCPBA (1.64 g, 9.54 mmol), 
the mixture was stirred for 30 min.  The solution was filtered, and diluted with CHCl3 (50 
mL). The organic phase was washed with sat. NaHCO3 soln. (2 x 20 mL), H2O (2 x 20 mL), 
dried (MgSO4) and the solvent removed under reduced pressure.  The resulting foam was 
purified by column chromatography using EtOAc:hexane (90:10) as eluant to yield a white 
solid (1.35 g, 63 %) Mp 177.6 oC; IR (KBr) ν 3422 (NH), 2923 (CH), 1743 (C=O), 1672 
(NHC=O), 1379 (CH), 1325 (O-C=O), 1222 (C-O-C), 1325 (SO2) and 1132 cm-1 (SO2); 1H 
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NMR (d-DMSO): δ 1.95 (3H, s, OAc), 1.96 (3H, s, OAc), 2.00 (3H, s, OAc), 2.02 (3H, s, 
OAc), 3.97 (1H, d, 2J = 15.0 Hz, SO2CH2CONH2), 4.20 (1H, d, 2J = 15.0 Hz, 
SO2CH2CONH2), 3.98-4.08 (2H, m, H-6), 4.21-4.30 (1H, m, H-5), 4.96 (1H, t, 3J = 4.8 Hz, 
H-4), 5.23 (1H, d, 3J = 9.0 Hz, H-1), 5.39 (1H, t, 3J = 9.0 Hz,  H-2), 5.48 (1H, t, 3J = 9.0 Hz, 
H-3), 7.49 (1H, br s, NH), 7.68 (1H, br s, NH’); 13C NMR δ 20.18 (CH3), 20.24 (CH3), 20.33 
(CH3), 20.47 (CH3), 55.10 (SO2CH2CONH2), 61.34 (C-6), 65.68 (C-4), 67.21 (C-2), 72.70 
(C-3), 74.88 (C-5), 85.75 (C-1), 162.37 (CONH2), 168.53 (OAc), 169.20 (OAc), 169.47 
(OAc), 170.03 (OAc). MS-ESI: Found m/z, 476.0832; calcd for C16H23NO12SNa [M+Na+], 
476.0839. 
 
 
 
3.3. Solid state characterisation 
Single-crystal X-ray diffraction measurements for 7 were collected on a Bruker APEX II 
DUO diffractometer and a Bruker SMART X2S was used for 3 and 9, as previously 
described.21  A Rigaku FR-E+ diffractometer fitted with VariMax HF optics to give 
monochromatized Mo Kα radiation was used for 10 following previously described 
procedures.22 Crystals suitable for analysis were obtained by recrystallisation from ethanol or 
methanol by slow evaporation. Calculations for 3, 7 and 9 were made using the APEX2 
v2009.3-0 software23 incorporating the SHELX suite of programs for structure solution and 
refinement.24 Calculations for 10 were made using CrystalClear-SM Expert 2.0 r13 
software.25 The structure was solved by Superflip26 and refined using SHELXL-97.24 All 
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diagrams were prepared using Mercury.27  The small crystal size of 7 and the relatively large 
number of unobserved data (47%) contribute to the high Rint value. 
 
Supplementary data 
The crystallographic data on compounds 3, 7, 9 and 10 have been deposited with the 
Cambridge Crystallographic Data Centre, CCDC numbers 919648 - 919651. These data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif  
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Figure Legends 
 
 
Scheme 1.  (a) HOCH2CO2Me, BF3.Et2O, CH2Cl2, −25 °C 4-5 h; (b) 2M NH3 in MeOH, rt, 
1 h; (c) BnNH2, THF, rt, 12 h; (d) CCl3CCN, DBU, CH2Cl2, 0 °C, 30 mins then rt, 12 h. 
 
 
Figure 1. View of crystal structure of compound 3 showing discrete hydrogen bond between 
primary amide N-H and pyranose oxygen forming C(7) chains. 
 
Figure 2. Illustration of discrete hydrogen bond between primary amide N-H and pyranose 
oxygen forming C(7) chains of compound 3 (depicted in red). 
 
 
Figure 3. View of crystal structure of compound 3 showing C(17) chains resulting from 
amide N-H hydrogen bond donation (to pyranose oxygen) and amide oxygen hydrogen bond 
acceptance (from primary hydroxyl) in compound 3. 
 
Figure 4. Illustration of C(17) chains resulting from amide N-H hydrogen bond donation (to 
pyranose oxygen) and amide oxygen hydrogen bond acceptance (from primary hydroxyl) in 
compound 3 (depicted in red).  
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Figure 5. View of the crystal structure of 7.MeOH solvate showing hydrogen bonding 
interactions of the primary amide groups. 
 
Figure 6. Illustration of the hydrogen bonding interactions of the primary amide groups in 
the structure of 7.MeOH solvate. 
 
 
 
Figure 7. View of the crystal structure of 7.MeOH solvate showing intramolecular S(7) and 
S(9), and intermolecular R 3 3 (9) hydrogen bonding motifs in the structure of 7.MeOH solvate. 
 
Figure 8. Intramolecular S(7) (depicted in blue), S(9) (depicted in green), and intermolecular 
R33(9) (depicted in red), hydrogen bonding motifs in the structure of 7.MeOH solvate. 
 
Figure 9.  Cross layering of cellobioside moieties of 7.MeOH viewed along the 
crystallographic b axis. 
 
 
Scheme 2.  (a) NH2CSNH2, BF3.Et2O, MeCN, ∆, 4 h, then ClCH2CONH2, Et3N, rt, 1 h; (b) 
Oxone®, MeCN, H2O, rt, 12 h; (c) mCPBA, CHCl3, 0 °C, rt, 30 mins. 
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Figure 10. View of the crystal structure of compound 9 showing hydrogen bonding 
interactions of the primary amide group. 
 
Figure 11. Illustration of hydrogen bonding interactions of the primary amide group in the 
structure of compound 9. 
 
 
Figure 12. View of the crystal structure of compound 10 showing hydrogen bonding 
interactions of the primary amide group. 
 
 
Figure 13. Illustration of hydrogen bonding interactions of the primary amide group in the 
structure of compound 10 forming R 2 3 (8) hydrogen bond patterns (depicted in red). 
 
Figure 14. Packing of molecules of compound 10. 
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Table 1. Crystallographic data 
Compound reference      3       7      9      10 
Chemical formula C8H15NO7 C15H29NO13 C16H23NO10S C16H23NO11S 
Formula mass 237.21 431.39 421.41 437.41 
Crystal system Monoclinic Monoclinic Orthorhombic Monoclinic 
a/Å 5.5981(8) 9.651(3) 7.3864(9) 9.1221(9) 
b/Å 6.9551(9) 8.387(3) 13.496(2) 5.5092(5) 
c/Å 13.5890(17) 12.638(5) 20.100(3) 21.085(2) 
β/° 101.378(4) 105.322(13) 90 91.474 (6) 
V/Å3 518.69(12) 986.6(6) 2003.7(5) 1059.29(17) 
Radiation used Mo Kα Mo Kα Cu Kα Cu Kα 
Crystal size/mm 0.45 x 0.32 x 
0.22 
0.11 x 0.09 x 
0.06 
0.47 x 0.23 x 
0.17 
0.20 x 0.01 x 
0.01 
Temperature/K 300(2) 296(2) 300(2) 100(2) 
Space group P21 P21 P212121 P21 
Z 2 2 4 2 
μ/mm-1 0.134 0.128 0.215 0.209 
No. of reflections measured 3715 10491 19356 5623 
No. of independent reflections 2038 3813 3823 4311 
Rint 0.0199 0.0908 0.0283 0.0352 
Final R1 values (I > 2σ(I)) 0.0345 0.0534 0.0297 0.0739 
Final wR(F2) values (I > 2σ(I)) 0.0840 0.0758 0.0864 0.1131 
Final R1 values (all data) 0.0399 0.1380 0.0367 0.0532 
Final wR(F2) values (all data) 0.0878 0.0976 0.1005 0.1131 
Goodness of fit on F2 1.055 0.950 1.123 1.044 
Flack parameter -1.8(11) 1.7(15) -0.01(7) -0.10(11) 
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Table 2. Hydrogen bond data 
Donor-H···Acceptor ARU D-H H···A D···A D-H···A 
      
Compound 3      
N(11)-H(11A)···O(6) -x, 0.5+y, 1-z 0.87(3) 2.18(3) 3.021(3) 162(3) 
N(11)-H(11B)···O(7) Intramolecular 0.87(3) 2.26(3) 2.648(3) 107(2) 
O(12)-H(12)···O(16) -1+x, 1+y, z 0.82 2.16 2.851(2) 142 
O(13)-H(13)···O(14) Intramolecular 0.82 2.56 2.8866(18) 105 
O(13)-H(13)···O(12) -x, -0.5+y, 2-z 0.82 2.08 2.8743(19) 162 
O(14)-H(14)···O(13) -x, -0.5+y, 2-z 0.82 1.86 2.6683(18) 168 
O(16)-H(16)···O(10) 1-x, -0.5+y, 1-z 0.82 1.96 2.768(2) 171 
C(3)-H(3)···O(14) 1-x, 0.5+y, 2-z 0.98 2.32 3.269(2) 163 
C(5)-H(5)···O(13) 1+x, y, z 0.98 2.45 3.398(2) 164 
C(8)-H(8A)···O(6) Intramolecular 0.97 2.43 2.816(2) 104 
C(8)-H(8A)···O(10) 1-x, -0.5+y, 1-z 0.97 2.51 3.456(3) 166 
C(15)-H(15A)···O(14) Intramolecular 0.97 2.59 2.984(2) 105 
      
Compound 7      
N(9)-H(9A)···O(24) 1-x, 1.5+y, 1-z 0.86 2.26 3.079(4) 159 
N(9)-H(9B)···O(7) Intramolecular 0.86 2.27 2.653(4) 107 
N(9)-H(9B)···O(12) 1-x, 0.5+y, 1-z 0.86 2.39 3.185(5) 153 
O(11)-H(11)···O(12) 1-x, 0.5+y, 1-z 0.82 1.95 2.728(4) 157 
O(12)-H(12)···O(13) Intramolecular 0.82 2.56 2.944(4) 110 
O(12)-H(12)···O(19) Intramolecular 0.82 1.95 2.762(4) 169 
O(20)-H(20)···O(22) 2-x, 0.5+y, 2-z 0.81(5) 2.05(5) 2.837(5) 167(5) 
O(21)-H(21)···O(28) 1-x, -0.5+y, 2-z 0.82 1.91 2.724(5) 173 
O(22)-H(22)···O(26) 2-x, -0.5+y, 2-z 0.82 1.93 2.748(4) 177 
O(24)-H(24)···O(11) 1-x, -0.5+y, 1-z 0.82 2.08 2.882(4) 165 
O(26)-H(26)···O(21) x, 1+y, z 0.82 1.94 2.716(4) 158 
O(28)-H(28)···O(10) x, -1+y, z 0.82 1.87 2.599(6) 148 
C(2)-H(2)···O(24) x, 1+y, z 0.98 2.60 3.516(5) 156 
C(5)-H(5)···O(20) 1-x, 0.5+y, 2-z 0.98 2.59 3.175(6) 118 
      
Compound 9      
N(11)-H(11A)···O(6) -0.5+x, 2.5-y, -z 0.86 2.24 3.045(2) 155 
N(11)-H(11B)···O(14) -1+x, y, z 0.86 2.15 2.978(3) 163 
C(2)-H(2)···O(14) Intramolecular 0.98 2.32 2.719(3) 104 
C(2)-H(2)···O(10) 0.5+x, 2.5-y, -z 0.98 2.47 3.330(3) 146 
C(3)-H(3)···O(18) Intramolecular 0.98 2.35 2.725(3) 102 
C(4)-H(4)···O(22) Intramolecular 0.98 2.31 2.686(2) 102 
C(15)-H(15B)···O(22) 0.5-x, 2-y, -0.5+z 0.96 2.46 3.289(3) 145 
C(19)-H(19C)···O(12) 0.5+x, 1.5-y, -z 0.96 2.56 3.438(3) 152 
C(23)-H(23A)···O(27) -x, -0.5+y, 0.5-z 0.96 2.51 3.461(4) 171 
C(24)-H(24B)···O(10) -0.5+x, 2.5-y, -z 0.97 2.58 3.331(3) 134 
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C(28)-H(28B)···O(22) -1+x, y, z 0.96 2.39 3.295(4) 157 
      
Compound 10      
N(1)-H(1A)···O(3) 1-x, 0.5+y, 1-z 0.88 1.99 2.871(4) 175 
N(1)-H(1B)···O(2) x, 1+y, z 0.88 2.29 3.074(4) 149 
C(2)-H(2)···O(11) Intramolecular 1.00 2.25 2.646(4) 102 
C(3)-H(3)···O(9) Intramolecular 1.00 2.25 2.701(5) 106 
C(4)-H(4)···O(7) Intramolecular 1.00 2.30 2.725(4) 104 
C(5)-H(5)···O(7) x, -1+y, z 1.00 2.37 3.346(4) 165 
C(6)-H(6B)···O(2) x, 1+y, z 0.99 2.08 3.007(4) 156 
C(10)-H(10A)···O(5) 1-x, -0.5+y, -z 0.98 2.56 3.501(5) 161 
C(10)-H(10B)···O(5) x, -1+y, z 0.98 2.60 3.406(5) 140 
C(12)-H(12B)···O(5) -1+x, y, z 0.98 2.50 3.440(5) 161 
C(14)-H(14A)···O(2) -1+x, 1+y, z 0.98 2.47 3.284(5) 140 
C(14)-H(14B)···O(9) x, 1+y, z 0.98 2.51 3.315(5) 139 
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Table 3. Cremer-Pople ring puckering coordinates7 
Compound Q / Å θ / ° φ / ° 
3 0.573(18) 8.38(18) 34.3(13) 
7 (reducing end) 0.574(4) 6.4(4) 73(4) 
7 (non-reducing end) 0.605(2) 7.9(4) 354(3) 
9 0.575(19) 3.42(18) 354(3) 
10 0.563(3) 11.1(4) 76.4(18) 
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Figure 14 
 
 
 
 
